Leiden

• A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended
  2023-503315-15-00 4 2023-12-20 Thrombolysis of symptomatic proximal vein thrombosis
• CBD, amitriptyline and tramadol drug-drug interaction study Ended
  2023-508428-36-00 4 2023-12-19 Neurological assessments
• Imatinib PD in healthy subjects Ended
  2023-504958-35-00 3 2023-12-13 Immuno-oncology assessments
• Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN Ended
  2023-504615-33-00 4 2023-12-12 colorectal livermetastases
• FLUOPANC II: A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guide … Ended
  2023-510481-27-00 4 2023-12-11 Pancreatic tumor
• Study to assess the effects of oral cannabidiol in healthy male subjects on CNS using the NeuroCart test battery and TMS. Ended
  2023-508311-23-00 4 2023-11-20 Neurological assessments
• A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cell … Ended
  2022-500782-27-00 7 2023-11-14 relapsed/refractory Multiple Myeloma
• Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended
  2023-504205-36-00 11 2023-11-01 Aortic stenosis
• A randomized, double-blind, double dummy, placebo-controlled, four-way cross-over study to investigate the analgesic effects and CNS effects … Ended
  2023-505793-15-00 3 2023-10-30 Chronic pain
• SAD and MAD study of VES001 Ended
  2023-505847-38-00 1 2023-10-11 Frontotemporal dementia (FTD)
• A Trial Investigating the pain-relieving properties of Lu AG06474 in Healthy Adult Participants Ended
  2023-503987-18-00 3 2023-10-03 Pain
• A Phase 1 Study of PRT3789 in Participants with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation Ended
  2022-502850-14-00 1 2023-09-25 gastroesophageal junction
• Comparison of multiple doses of intramuscular versus intranasal naloxone for reversal of opioid toxicity Ended
  2023-505338-93-00 4 2023-09-21 Healthy volunteers
• Evaluation of sensory testing to measure the effects of tetrodotoxin Ended
  2022-500318-24-00 4 2023-08-30 pain
• PREPARE-iVAC Ended
  2023-503894-39-00 11 2023-08-22 kidney transplantation
• A study of the safety of the new investigational drug CVN293 in healthy volunteers, and how CVN293 is taken up and processed by the human bo … Ended
  2023-506114-49-00 1 2023-08-15 Neurodegenerative disorders
• Hypoxic ventilatory response (HVR): Effect of Esketamine Ended
  2023-504229-37-00 6 2023-08-04 healthy volunteers
• SAD and MAD of VENT-02 in healthy volunteers Ended
  2023-505546-26-00 1 2023-07-21 Neuroinflammatory and neurodegenerative diseases
• Effect of a pain killer on breathing and another drug that stimulates breathing Ended
  2023-503912-34-00 11 2023-07-19 none, healthy subjects only
• Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis Ended
  2023-506046-24-00 4 2023-07-03 Ulcerative Colitis (UC)
• A Phase 2, Single-Blind, Placebo-Controlled Trial to Evaluate the Photoparoxysmal Electroencephalogram Response, Safety, Tolerability, and P … Ended
  2023-504803-10-00 4 2023-06-15 IPS induced photoparoxysmal electroencephalogram response (IPS-induced
• MERCURI-2 Ended
  2024-515260-31-00 6 2023-06-09 AKI
• Transcranial Magnetic Stimulation (TMS) Evaluation of Central Nervous System (CNS) Pharmacodynamic (PD) Activity of Brexanolone in Healthy M … Ended
  2022-503019-40-00 3 2023-05-11 NA, PD study in Healthy Volunteers
• Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended
  2024-512558-40-00 4 2023-05-11 Mild-to-moderate ulcerative colitis

Showing 385–408 of 459 trials